Table 2 The effect of treatment on clinical parameters in patients with IgAN.

From: Increased frequency of PD-1hiCXCR5- T cells and B cells in patients with newly diagnosed IgA nephropathy

 

Before treatment

After treatment

Age, years

40(26–58)

40 (26–58)

Female/Male

4/2

4/2

Serum IgA, g/L

3.26 (1.79–4.88)

3.09 (2.18–3.75)

Urinary protein, g/24 h

5.19 (0.98–9.50)

2.61 (0.47–5.54)*

Serum uric acid, μmol/L

381 (326–451)

369.83 (217–431)

Triglycerides, mmol/L

1.85 (0.90–3.12)

1.79 (1.12–2.98)

Cholesterol, mmol/L

6.92 (2.80–9.95)

5.85 (2.67–8.33)

eGFR, mL/min/1.73 m2

66.89 (32.1–119)

86.83 (41.3–115)*

serum albumin, g/L

24.8 (12.1–31)

31.72 (27.3–40.6)

WBC, 109/L

6.44 (4.96–8.12)

6.79 (5.37–8.44)

Lymphocytes, 109/L

1.56 (1.21–2.58)

1.49 (0.37–2.34)

  1. Data are present as median (range). *P < 0.05 vs. the values before treatment.
Back to article page